1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Diagnostics Focus 25 MAY 2015

Diagnostics Focus 25 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Danaher Focuses On Life Sciences Following Pall Acquisition
Industry Brief - Hospira To Provide Theradiag's Lisa Tracker Infiximab Monitoring Kit With Inflectra
Industry Brief - Merck Millipore Acquires Rights To Singulex' SMC Technology
Industry Brief - AstraZeneca/Abbott To Co-Develop Companion Diagnostics For Tralokinumab
Industry Brief - Vivione's Share Purchase Deal With Trillium Expires
Industry Brief - Endress+Hauser Set For Analytik Jena Takeover
Industry Brief - Nihon Kohden To Reorganise Group Companies In Europe
Industry Brief - Illumina Files Prenatal Testing Suit Against Ariosa/Roche
Industry Trend Analysis - OctreoPharm Acquisition Will Strengthen Ipsen's NET Presence
Industry Brief - MBio Raises Funds For Diagnostics Platform
Industry Trend Analysis - CareFusion Acquisition Will Help Offset Foreign Currency Headwinds
Industry Brief - PrecisionPath Colon NGS Panel Launched In US
Industry Brief - Rosetta Offers FGFr3 Gene Mutation Assays For BC
Industry Brief - Theradiag Launches Lisa Tracker Range In Canada
Industry Brief - LabCorp Offers Two HCV Drug-Resistance Assays In US
Industry Brief - FDA Grants CLIA Waiver For cobas Strep A Assay
Industry Brief - CHL's Universal MPO Assay Secures CE Mark And ISO/CMDCAS Certifications
Industry Brief - Resolution Bio Gets CLIA Certification; Launches ctDx ALK Liquid Biopsy
Industry Brief - GeneStrat Targeted Liquid Biopsy Mutation Test Launched In US
Industry Brief - Meridian Secures CE Mark For illumigene HSV 1/2 Assays
Industry Brief - NCC/Takeda Partner To Develop Anticancer Agents
Industry Brief - Rosetta Granted US Patent Allowance Covering Cancer Origin Test
Industry Brief - UCL Develops Rapid Identification Test For Resistant TB
Industry Brief - FDA Denies LuViva PMA
Industry Brief - Diagnostic Conferences - May 2015

Table Of Contents

Diagnostics Focus 25 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.